ClinicalTrials.Veeva

Menu

Long-term Effects of Transcranial Direct Current Stimulation (tDCS) on Patients With Phantom Limb Pain (PLP)

S

Sheba Medical Center

Status

Suspended

Conditions

Phantom Limb Pain

Treatments

Device: Sham + Cathodal stimulation of M1
Device: Sham + Anodal stimulation of M1
Device: Cathodal stimulation of M1 + sham
Device: Anodal stimulation of M1 + sham

Study type

Interventional

Funder types

Other

Identifiers

NCT02051959
SHEBA-13-0733-IS-CTIL

Details and patient eligibility

About

  • Phantom limb pain (PLP) refers to pain in a limb that has been amputated or deafferented. Phantom limb pain might be related to brain cortical plastic changes.
  • The purpose of this study is to determine the efficacy of a series of transcranial direct current stimulation (tDCS) sessions, a non-invasive and focal brain stimulation method, in producing long-term reduction of phantom limb pain among amputees who experience such pain.

This is a Crossover sham control.

Enrollment

24 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age 18 to 80
  • Limb amputation from at least 6 months before study enrollment
  • Presence of PLP at least 2 times a week and present 4 weeks prior to onset of study
  • Written informed consent

Exclusion criteria

  • Coexistence of major neurological or psychiatric diseases
  • Being actively enrolled in a separate study targeting pain relief
  • Post traumatic stress disorder (PTSD) diagnosed patients
  • Any contraindication to noninvasive brain stimulation such as past brain surgery, brain implants, cochlear implant, epilepsy or any past seizure
  • Pregnant women
  • Within the traumatic amputees group - subjects diagnosed with diabetes

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

24 participants in 4 patient groups

Crossover 1a: anodal stimulation of M1 + sham
Active Comparator group
Description:
6 amputees will undergo 8 active treatments of 20 min 2mA anodal stimulation of M1 localized to the contralateral amputation area followed by 8 sham treatments. Total duration and frequency of treatments: 8 weeks, 2 sessions per week. Each session will last approximately one hour which will consist of: * EEG and pain measurements * 20 minutes of stimulation * EEG and pain measurements after completion of stimulation
Treatment:
Device: Anodal stimulation of M1 + sham
Crossover 1b: sham + anodal stimulation of M1
Active Comparator group
Description:
6 amputees will undergo 8 sham treatments followed by 8 active treatments of 20 min 2mA anodal stimulation of M1 localized to the contralateral amputation area. Total duration and frequency of treatments: 8 weeks, 2 sessions per week. Each session will last approximately one hour which will consist of: * EEG and pain measurements * 20 minutes of stimulation * EEG and pain measurements after completion of stimulation
Treatment:
Device: Sham + Anodal stimulation of M1
Crossover 2a: cathodal stimulation of M1 + sham
Active Comparator group
Description:
6 amputees will undergo 8 active treatments of 20 min 2mA cathodal stimulation of M1 localized to the contralateral amputation area followed by 8 sham treatments. Total duration and frequency of treatments: 8 weeks, 2 sessions per week. Each session will last approximately one hour which will consist of: * EEG and pain measurements * 20 minutes of stimulation * EEG and pain measurements after completion of stimulation
Treatment:
Device: Cathodal stimulation of M1 + sham
Crossover 2b: sham + cathodal stimulation of M1
Active Comparator group
Description:
6 amputees will undergo 8 sham treatments followed by 8 active treatments of 20 min 2mA cathodal stimulation of M1 localized to the contralateral amputation area. Total duration and frequency of treatments: 8 weeks, 2 sessions per week. Each session will last approximately one hour which will consist of: * EEG and pain measurements * 20 minutes of stimulation * EEG and pain measurements after completion of stimulation
Treatment:
Device: Sham + Cathodal stimulation of M1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems